Ocular toxicity of systemic medications: a case series

T Q To1, J C Townsend

  • 1VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, California, USA.

Optometry (St. Louis, Mo.)
|February 19, 2000
PubMed
Abstract

Insights

Systemic medications can cause serious eye problems, but regular monitoring by eye care practitioners can prevent or reduce these risks. Updated guidelines are needed to manage ocular toxicity from common drugs.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Clinical Medicine

Background:

  • Long-term systemic medication use can lead to visually threatening conditions.
  • Proactive patient monitoring is crucial for mitigating adverse ocular effects.
  • Current clinical guidelines require updates for monitoring drug-induced ocular toxicity.

Observation:

  • Ocular toxicity has been reported with isoniazid, thioridazine, steroids, and amiodarone.
  • Clinical cases include isoniazid-induced optic neuropathy and steroid-induced glaucoma.
  • Phenothiazine-induced retinopathy and amiodarone-related vortex epitheliopathy are also noted.

Findings:

  • Systemic drugs pose significant risks for ocular health.
  • Specific medications like isoniazid, thioridazine, steroids, and amiodarone are associated with distinct toxicities.
  • Early detection of ocular side effects is possible through vigilant monitoring.

Implications:

  • Eye care practitioners must be aware of potential ocular side effects from systemic drugs.
  • Development of evidence-based monitoring guidelines is essential for optometrists.
  • Implementing updated guidelines can improve patient outcomes and prevent vision loss.

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...